Acetic acid 3,5-diacetoxy-2-acetoxymethyl-6-mercapto-tetrahydro-pyran-4-yl ester | 610300-66-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Acetic acid 3,5-diacetoxy-2-acetoxymethyl-6-mercapto-tetrahydro-pyran-4-yl ester
• 英文别名: (3,4,5-Triacetyloxy-6-sulfanyloxan-2-yl)methyl acetate
• CAS: 610300-66-8
• 化学式: C₁₄H₂₀O₉S
• 分子量: 364.373
• InChiKey: SFOZKJGZNOBSHF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  24
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  115
• 氢给体数：
  1
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  、 Acetic acid 3,5-diacetoxy-2-acetoxymethyl-6-mercapto-tetrahydro-pyran-4-yl ester 在 三乙胺 作用下， 以 乙腈 为溶剂， 生成
  参考文献：
  名称：

  Adam, Michael J.; Hall, Laurance D., Canadian Journal of Chemistry, 1980, vol. 58, p. 1188 - 1197

  摘要：

  DOI：

文献信息

• TARGETED PEPTIDE CONJUGATES
  申请人：Marker Gene Technologies, Inc.

  公开号：US20180207287A1

  公开（公告）日：2018-07-26

  The present invention relates to the preparation and use of therapeutic compounds for the treatment of diseases at specific subcellular target areas such as specific cellular organelles. In particular, the therapeutic compounds of the invention are specific for modifying enzyme activity within targeted organelles or structures of cells and tissues. Subcellular organelles and structures that may be specifically targeted by compounds of the present invention include lysosomes, autophagasomes, the endoplasmic reticulum, the Golgi complex, peroxisomes, the nucleus, membranes and the mitochondria.

  本发明涉及制备和使用治疗化合物，用于治疗特定亚细胞靶区域的疾病，如特定细胞器。具体来说，本发明的治疗化合物特异地用于修改靶向细胞和组织的细胞器或结构内的酶活性。本发明的化合物可以特异地靶向的亚细胞器和结构包括溶酶体、自噬体、内质网、高尔基体、过氧化物酶体、细胞核、细胞膜和线粒体。
• [EN] METHODS FOR THE SYNTHESIS OF FUNCTIONALIZED NUCLEIC ACIDS<br/>[FR] PROCÉDÉS POUR LA SYNTHÈSE D'ACIDES NUCLÉIQUES FONCTIONNALISÉS
  申请人：ONTORII INC

  公开号：WO2013012758A1

  公开（公告）日：2013-01-24

  Described herein are methods for the synthesis of derivatives of thiosulfonate reagents. Said reagents have utility for the synthesis of phosphorothiotriesters from H- phosphonates in a stereospecific fashion.

  本文描述了一种合成硫代磺酸盐试剂衍生物的方法。该试剂对于从H-磷酸酯立体特异性合成磷硫三酯具有实用性。
• Reagents And Methods For The Formation Of Disulfide Bonds And The Glycosylation Of Proteins
  申请人：Davis Guy Benjamin

  公开号：US20070213506A1

  公开（公告）日：2007-09-13

  Methods and reagents for the formation of disulfide bonds, particularly in proteins, peptides and amino acids. The methods and reagents are particularly useful for the controlled glycosylation of proteins, peptides and amino acids. The methods utilise thiosulfonate or selenenylsulfide compounds as reagents or intermediates. Some proteins and peptides comprising selenenyl-sulfide groups also form part of the invention.

  本发明涉及在蛋白质、肽和氨基酸中形成二硫键的方法和试剂，特别是用于蛋白质、肽和氨基酸的可控糖基化。所述方法利用硫代磺酸盐或硒酰硫酸盐化合物作为试剂或中间体。一些含有硒酰硫酸盐基团的蛋白质和肽也是本发明的一部分。
• ISOTHIOCYANATES AND GLUCOSINOLATE COMPOUNDS AND ANTI-TUMOR COMPOSITIONS CONTAINING SAME
  申请人：Rajski Scott R.

  公开号：US20080312164A1

  公开（公告）日：2008-12-18

  The present invention provides glucosinolate and isothiocyante compounds and related methods for synthesizing these compounds and analogs. In certain embodiments, these glucosinolate and isothiocyanate compounds are useful and chemopreventive and or chemotherapeutic agents.

  本发明提供了葡萄糖硫醇和异硫氰酸化合物及其相关合成方法和类似物。在某些实施例中，这些葡萄糖硫醇和异硫氰酸化合物是有用的化学预防和/或化学治疗剂。
• TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS
  申请人：Savarino Andrea

  公开号：US20110305774A1

  公开（公告）日：2011-12-15

  Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present invention is: A) the capacity of reactivating HIV-1 from latency, and B) the ability to counteract the cellular machinery which activates in order to limit the effects of oxidative stress. In this way, oxidative stress can be potentiated and a “chain reaction” is sparked. This “chain reaction” induces a more efficient reactivation of HIV-1 from latency and, in some cases, induces selective killing of the infected cells. Actions A) and B) can either be carried out by one drug exerting both effects, or obtained by the combined use of distinct drugs. There are two main cellular machineries counteracting oxidative stress, i.e. the thioredoxin (Trx) thioredoxin reductase (TrxR) system and glutathione. Herein, we present drug strategies capable of exerting action B) by blocking either of the two machineries.

  HIV-1复制的激活会引起氧化应激，从而加强HIV-1的复制。本发明化合物的共同基础是：A）重新激活HIV-1潜伏感染的能力，和B）对抗细胞机制，以限制氧化应激的影响。通过这种方式，氧化应激可以被增强并引发“连锁反应”。这种“连锁反应”诱导更有效的HIV-1潜伏感染的重新激活，并在某些情况下诱导感染细胞的选择性杀死。行动A）和B）可以由一种药物实现两种效果，也可以通过联合使用不同药物获得。对抗氧化应激的两种主要细胞机制是硫氧还蛋白（Trx）硫氧还蛋白还原酶（TrxR）系统和谷胱甘肽。在此，我们提出了能够通过阻断这两种机制之一来实现B）行动的药物策略。